Siemens - statistics & facts
Siemens is a Germany-based company specialized in engineering, electronics, and medical electrical devices. As of 2021, Siemens was the leading automation vendor worldwide and the fifth largest conglomerate in the world. In the same year, Siemens generated total revenue of about 62 billion euros from its various businesses.
The company was originally founded in 1847 as an electrical engineering company that produced electrical telegraphs, and eventually broadened its scope to include telegraph lines, constructing the world’s first electric streetcar line. Throughout the 20th and early 21st centuries, Siemens acquired and combined with various other companies to increase its capabilities, expanding its specializations into the various sectors in which it operates today, including industry, energy, healthcare, infrastructure, and cities.
During the COVID-19 pandemic, Siemens Healthineers started collaborating with a pharmaceutical company GSK to digitalize the development and manufacture of the COVID-19 vaccine. As of March 2021, the GSK/Sanofi vaccine was ordered in over 700 million doses. Moreover, Siemens is currently producing one of the top-performing rapid antigen tests and antibody tests.
The company was originally founded in 1847 as an electrical engineering company that produced electrical telegraphs, and eventually broadened its scope to include telegraph lines, constructing the world’s first electric streetcar line. Throughout the 20th and early 21st centuries, Siemens acquired and combined with various other companies to increase its capabilities, expanding its specializations into the various sectors in which it operates today, including industry, energy, healthcare, infrastructure, and cities.
Siemens Healthineers as the best performing segment in 2021
The Healthineers division was Siemens AG's most profitable business unit in 2021, with revenue of almost 18 billion euros. This segment aims to manufacture medical devices by using new technologies such as artificial intelligence, automation and robotics, and sensing. To catch up with these core technologies, Siemens AG invested 4.9 billion euros into research and development within the company.During the COVID-19 pandemic, Siemens Healthineers started collaborating with a pharmaceutical company GSK to digitalize the development and manufacture of the COVID-19 vaccine. As of March 2021, the GSK/Sanofi vaccine was ordered in over 700 million doses. Moreover, Siemens is currently producing one of the top-performing rapid antigen tests and antibody tests.
